Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008215
Filing Date
2017-05-03
Accepted
2017-05-03 07:06:22
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-10q_20170331.htm 10-Q 1629436
2 EX-31.1 amrn-ex311_8.htm EX-31.1 16351
3 EX-31.2 amrn-ex312_7.htm EX-31.2 16749
4 EX-32.1 amrn-ex321_6.htm EX-32.1 9889
  Complete submission text file 0001564590-17-008215.txt   6763511

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amrn-20170331.xml EX-101.INS 1454219
6 XBRL TAXONOMY EXTENSION SCHEMA amrn-20170331.xsd EX-101.SCH 49303
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20170331_cal.xml EX-101.CAL 40960
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20170331_def.xml EX-101.DEF 208835
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20170331_lab.xml EX-101.LAB 400052
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20170331_pre.xml EX-101.PRE 326264
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 17807122
SIC: 2834 Pharmaceutical Preparations